Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial

Hyperimmune plasma from patients convalescing from COVID-19 is a potential treatment for severe COVID-19 in other patients. We conducted a multicenter, one-arm, proof-of-concept interventional study. Patients with COVID-19 with moderate-to-severe acute respiratory distress syndrome, elevated C-react...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Haematologica
Auteurs principaux: Perotti, Cesare, Baldanti, Fausto, Bruno, Raffaele, Del Fante, Claudia, Seminari, Elena, Casari, Salvatore, Percivalle, Elena, Glingani, Claudia, Musella, Valeria, Belliato, Mirko, Garuti, Martina, Meloni, Federica, Frigato, Marilena, Di Sabatino, Antonio, Klersy, Catherine, De Donno, Giuseppe, Franchini, Massimo
Format: Artigo
Langue:Inglês
Publié: Fondazione Ferrata Storti 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7716363/
https://ncbi.nlm.nih.gov/pubmed/33256382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.261784
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires